NervGen Pharma (9UA.F) Q3 2026 Earnings

12AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-0.08
-0.06
-0.04
-0.01

Details

Expected EPS
-0.06492946408
Actual EPS
N/A
Surprise EPS
0.06
Surprise Percent
+100%

Description

NervGen Pharma (9UA.F) will report earnings of for Q3 2026 on August 12, 2026.

0 Comments

Share your thoughts